Top line results from phase 2b trial of BIOD-531
Insulin-treated type 2 diabetes
RedHill Biopharma Ltd.
Top-line data Phase 3 study of Bekinda (GUARD study)
Acute gastroenteritis and gastritis
GW Pharmaceuticals PLC
Data from phase 1b/2a study of GWP42002:GWP42003
Recurrent Glioblastoma Multiforme
Topline data from phase 3 study of DRM04i
Ultragenyx Pharmaceutical Inc
Safety and efficacy data from Phase 3 trial of rhGUS
Mucopolysaccharidosis 7 (MPS 7)
Topline data from phase 3 study of Ganaxolone Capsule
Refractory Focal Onset Seizures:
Full data from Phase 2 trial for PCDH19
Female Pediatric Epilepsy
Rigel Pharmaceuticals Inc.
Topline data from 1st phase 3 trial of Fostamatinib
Immune thrombocytopenic purpura
Vertex Pharmaceuticals Inc.
Results from phase 2a study of inhaled VX-371
Topline data from phase II study of Bempedoic acid
Lowering LDL cholesterol
Sophiris Bio Inc.
Final data from phase Phase 2a proof of concept study of PRX302
Oramed Pharmaceuticals Inc.
Topline data from phase IIb trial of ORMD-0801
Type 2 Diabetes
ProNAi Therapeutics Inc
Initial data from Phase 2 monotherapy trial of PNT2258 ( Wolverine)
Relapsed or refractory diffuse large B-cell lymphoma,
Prothena Corporation plc
Topline results from expansion cohort of a phase 1/2 study of NEOD001
Topline data from Phase 3 trial of Niraparib (NOVA)
Report topline data from phase 2 trial of Niraparib (QUADRA)
Top-line data from phase 2b trial of TRV027 (BLAST-AHF )
Acute Heart Failure
Minerva Neurosciences Inc
Topline results from phase IIb study of MIN-101
Improving negative symptoms of schizophrenia.
Topline results from phase 2b trial DRM01
Topline results from 1st & 2nd phase 3 trials of XaraColl (MATRIX-1 & MATRIX-2)
Final data from phase 2a trial of AFM13
01-Mar-2016 To 30-Apr-2016
Biomarin Pharmaceutical Inc.
Topline results from Phase 3 trial with PEG PAL
Flexion Therapeutics, Inc.
Topline data from phase 3 trial of Zilretta
Osteoarthritis knee pain
Aldeyra Therapeutics, Inc.
Data from phase II trial of NS2
Data from phase 3 trial of ALKS 5461 (FORWARD-3 and FORWARD-4)
Major depressive disorder